Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03210337 · ClinicalTrials.gov registry record · Phase 2
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Phase 2 study, sponsored by Aclaris Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 157
- Enrollment target
NCT03210337 is a Phase 2 study that has completed, run by Aclaris Therapeutics. The registered enrollment target is 157 participants.
The verdict
NCT03210337, a Phase 2 study, has completed, sponsored by Aclaris Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 157 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the effectiveness of A-101 compared to vehicle when applied to 1 common target wart on the trunk or extremities.
Interventions
- DRUG A-101 Topical Solution
- DRUG A-101 Vehicle Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2018-03-16 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03210337
The ClinicalTrials.gov registry entry for NCT03210337 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 157 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aclaris Therapeutics, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which A-101 Topical Solution is the first listed.
NCT03210337 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03210337 about?
NCT03210337 is a clinical study titled "A Phase2 of A-101 Topical Solution in Subjects With Common Warts". The primary objective of this study is to evaluate the effectiveness of A-101 compared to vehicle when applied to 1 common target wart on the trunk or extremities.
What is the current status of trial NCT03210337?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 157 participants. The study started on 2017-08-01. Estimated completion is 2018-03-16.
What interventions are being tested in trial NCT03210337?
The interventions under investigation include: A-101 Topical Solution (DRUG), A-101 Vehicle Solution (DRUG).
Who is sponsoring clinical trial NCT03210337?
This trial is sponsored by Aclaris Therapeutics, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.